BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 3581706)

  • 21. Treatment of polymyalgia rheumatica and giant cell arteritis. I. Steroid regimens in the first two months.
    Kyle V; Hazleman BL
    Ann Rheum Dis; 1989 Aug; 48(8):658-61. PubMed ID: 2782975
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Circulating levels of IL-1beta, IL-6 and soluble IL-2 receptor in polymyalgia rheumatica and giant cell arteritis and rheumatoid arthritis.
    Pountain G; Hazleman B; Cawston TE
    Br J Rheumatol; 1998 Jul; 37(7):797-8. PubMed ID: 9714363
    [No Abstract]   [Full Text] [Related]  

  • 23. Antibodies to cardiolipin and beta 2 glycoprotein I in patients with polymyalgia rheumatica and giant cell arteritis.
    Meyer O; Nicaise P; Moreau S; de Bandt M; Palazzo E; Hayem G; Chazerain P; Labarre C; Kahn MF
    Rev Rhum Engl Ed; 1996 Apr; 63(4):241-7. PubMed ID: 8738442
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Polymyalgia rheumatica. Primary symptoms: muscle pain, malaise].
    Nigg C; Naumann UK; Käser L; Vetter W
    Praxis (Bern 1994); 2007 Oct; 96(44):1705-11; quiz 1712-3. PubMed ID: 18018947
    [No Abstract]   [Full Text] [Related]  

  • 25. Recognition and management of polymyalgia rheumatica and giant cell arteritis.
    Caylor TL; Perkins A
    Am Fam Physician; 2013 Nov; 88(10):676-84. PubMed ID: 24364483
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Serial IL-6 measurements in patients with tocilizumab-treated large-vessel vasculitis detect infections and may predict early relapses.
    Berger CT; Rebholz-Chaves B; Recher M; Manigold T; Daikeler T
    Ann Rheum Dis; 2019 Jul; 78(7):1012-1014. PubMed ID: 30670375
    [No Abstract]   [Full Text] [Related]  

  • 27. Polymyalgia rheumatica and giant cell arteritis.
    Ettlinger RE; Hunder GG; Ward LE
    Annu Rev Med; 1978; 29():15-22. PubMed ID: 348031
    [No Abstract]   [Full Text] [Related]  

  • 28. ESR in polymyalgia rheumatica and giant cell arteritis.
    Jones JG; Hazleman BL
    Ann Rheum Dis; 1983 Dec; 42(6):702-3. PubMed ID: 6651374
    [No Abstract]   [Full Text] [Related]  

  • 29. Lipoprotein(a) and anticardiolipin antibodies as risk factors for thrombotic events in polymyalgia rheumatica and giant cell arteritis.
    Seriolo B; Accardo S; Cutolo M
    J Rheumatol; 1996 Aug; 23(8):1478-80. PubMed ID: 8856634
    [No Abstract]   [Full Text] [Related]  

  • 30. Temporal arteritis and polymyalgia rheumatica. Clinical and biopsy findings.
    Fauchald P; Rygvold O; Oystese B
    Ann Intern Med; 1972 Dec; 77(6):845-52. PubMed ID: 4644163
    [No Abstract]   [Full Text] [Related]  

  • 31. The effect of clinical features and glucocorticoids on biopsy findings in giant cell arteritis.
    Jakobsson K; Jacobsson L; Mohammad AJ; Nilsson JÅ; Warrington K; Matteson EL; Turesson C
    BMC Musculoskelet Disord; 2016 Aug; 17(1):363. PubMed ID: 27558589
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Rhizomelic pseudopolyarthritis (polymyalgia rheumatica) and the problem of very high sedimentation rates].
    Saudan Y; Chavannes F
    Helv Med Acta Suppl; 1969; 49():191-5. PubMed ID: 5268893
    [No Abstract]   [Full Text] [Related]  

  • 33. Letter: Polymyalgia rheumatica and liver disease.
    Gibbs P
    Lancet; 1974 Mar; 1(7853):351-2. PubMed ID: 4131185
    [No Abstract]   [Full Text] [Related]  

  • 34. [C-reactive protein or blood sedimentation reaction os preventive studies in the physician's laboratory?].
    Steiner A; Vetter W
    Ther Umsch; 1995 May; 52(5):350-4. PubMed ID: 7770822
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Polymyalgia rheumatica and giant cell arteritis--a difficult diagnosis.
    Jones JG; Hazleman BL
    J R Coll Gen Pract; 1981 May; 31(226):283-9. PubMed ID: 7310759
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Cardiolipin antibodies in rheumatic polymyalgia and Horton's disease].
    Rytikova MI; Bunchuk NV; Kovalev VIu; Nasonov EL
    Klin Med (Mosk); 1993; 71(2):33-6. PubMed ID: 8046920
    [No Abstract]   [Full Text] [Related]  

  • 37. Giant cell arteritis and polymyalgia rheumatica in northwestern Turkey: Clinical features and epidemiological data.
    Pamuk ON; Dönmez S; Karahan B; Pamuk GE; Cakir N
    Clin Exp Rheumatol; 2009; 27(5):830-3. PubMed ID: 19917168
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Rheumatic polymyalgia and temporal arteritis. Case contribution and bibliographic review].
    Manganelli P; Mercadanti M; Nervetti A; Ambanelli U
    Minerva Med; 1987 Mar; 78(5):287-96. PubMed ID: 3822219
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Polymyalgia rheumatica and temporal arteritis].
    Persijn JP
    Ned Tijdschr Geneeskd; 2005 Nov; 149(45):2535; author reply 2536-7. PubMed ID: 16304892
    [No Abstract]   [Full Text] [Related]  

  • 40. Anticardiolipin antibodies in northern Italian population with PMR/GCA.
    Salvarani C; Baricchi R; Macchioni P; Carbognani R; Morelli A; Lodi L; Portioli I
    Am J Med; 1992 Jun; 92(6):712-4. PubMed ID: 1605162
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.